INHBA was found to be a novel mediator regulating cellular senescence and immune evasion [44] and as a prognostic predictor for patients with colon adenocarcinoma [45], consistent with our findings of INHBA as a potential biomarker. Here, INHBA is linked to colon adenocarcinoma.